Autism Spectrum Disorder Trial, Recruiting NCT03222375 Sponsor: American Federation of Medical Synergetics Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT03222375
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a clinical diagnosis of autism or a related condition.
  • People who have a history of late complications from birth-related trauma, specifically brain injury, injury to the vertebrae in the neck area, or reduced oxygen to the brain at birth.
  • People who have identified difficulties with language, and/or other thinking or behavioural challenges (the specific details depend on which part of the study a person is enrolled in).
  • People who are able to perform research tasks suited to their age group: infants (over 1 month up to 2 years old), children (over 2 up to 12 years old), or adolescents (over 12 up to 21 years old).
  • People who have certain specific patterns visible on their skin relating to hair growth direction, as assessed using the study's own diagnostic methods (confirm with trial site).
  • People for whom a specific clinical protocol called CRF-SQUED™ has been completed, which includes a series of diagnostic and mathematical modelling steps used by the research team (confirm with trial site).
  • People for whom a magnetic reading of their home location and its geographic coordinates has been recorded (confirm with trial site).

Who may not be able to join:

  • People who have blindness affecting their peripheral (outer field) vision, as this prevents the use of one of the study's image-based devices.
  • People who have deafness affecting their peripheral hearing, as this prevents the use of one of the study's sound-based devices.
  • People who have any metal device implanted in their body, as this prevents the use of one of the study's electromagnetic devices.
  • People who have an implanted heart pacemaker, as this prevents the use of one of the study's electromagnetic devices.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yuliya Yaroshuk, M.D.s. Ph.D., World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS

Phone: 502-338-0861

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
American Federation of Medical Synergetics
Registry
ClinicalTrials.gov
Start date
26 September 2017
Est. completion
1 September 2022

Where this trial is recruiting

🇺🇦 Ukraine 🇺🇸 United States

Primary endpoints

SQUED™ software of patient

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov